CONFOUNDING BY SEVERITY AND INDICATION IN OBSERVATIONAL STUDIES OF ANTIDEPRE SSANT EFFECTIVENESS
Main Article Content
Keywords
Antidepressive agent, longitudinal studies, epidemiology, methods
Abstract
Background
It has been suggested that antidepressants worsen the course of major depressive disorder. Epidemiological data have sometimes been cited in support of this idea, but such estimates are vulnerable to confounding. The objective of this study was to assess episode incidence and recovery in relation to antidepressant use, adjusting for symptom severity.
Methods
Random digit dialing was used to select a sample of n=3304 community residents. Each respondent was then assessed with a baseline interview followed by a series of six subsequent interviews spaced two weeks apart. The brief Patient Health Questionnaire (PHQ-9) was used to detect depressive episodes during follow-up and to provide ratings of symptom severity. Grouped time proportional hazards models were used to assess confounding by producing estimates of the association between antidepressant use and major depression incidence and prognosis adjusted for baseline symptom severity.
Results
Antidepressant use in initially non-depressed respondents was associated with a markedly higher incidence of depression (Hazard Ratio, HR = 3.9, 95% CI 1.8 – 8.5). With adjustment for the depression severity score in the two weeks preceding the emergence of a new episode, this effect diminished markedly and was no longer statistically significant (HR = 1.2, 95% CI 0.6 – 2.7, p = 0.57). Antidepressant use was also associated with a lower rate of recovery from major depression (HR = 0.8, 95% CI 0.5 – 1.2, p = 0.27), but this effect also moved towards the null value after adjustment for baseline severity (HR = 0.9, 95% CI 0.6 – 1.5).
Conclusions
Antidepressant medication use is confounded with symptom severity. Observational studies seeming to show harmful effects of antidepressants are subject to bias as a result.
References
2. Moncrieff J. Are antidepressants overrated? A review of methodological problems in antidepressant clinical trials. J Nerv Ment Dis 2001;189:288-95.
3. Turner EH, Matthews AM, Linardatos E, et al. Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy. New Eng J Med 2008;358:252-60.
4. Fava GA. Can long-term treatment with antidepressant drugs worsen the clinical course of depression? J Clin Psychiatry 2003;64:123-33.
5. Patten SB. The impact of antidepressant treatment on population health: Synthesis of data from two national data sources in Canada. Population Health metrics 2004;2/1/9.
6. Brugha TS, Bebbington PE, MacCarthy B, et al. Antidepressants may not assist recovery in practice: a naturalistic prospective survey. Acta Psychiatr Scand 1992;86:5- 11.
7. Moncrieff J. Are antidepressants as effective as claimed? No, they are not effective at all. Can J Psychiatry 2007;52:96-7.
8. Patten SB. In debate: Are antidepressants as effective as claimed? ( Letter). Can J Psychiatry 2007;52:750.
9. Spitzer RL, Kroenke K, Williams JBW, et al. Validation and utility of a self-report version of the PRIME-MD. The PHQ Primary Care Study. JAMA 1999;282:1737-44.
10. Spitzer RL, Williams JBW, Kroenke K, et al. Validity and utility of the PRIME-MD Patient Health Questionnaire in assessment of 3000 obstetric- gynecologic patients: The PRIME- MD Patient Health Questionnaire Obstetric- Gynecology Study. Am J Obstet Gynecol 2000;183:759-69.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders(DSM- IV-TR). Washington: American Psychiatric Association; 2000.
12. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. Validity of a brief depression severity measure. J Gen Intern Med 2001;16:606 -13.
13. Patten SB. A visual depiction of major depression epidemiology. BMC Psychiatry 2007;7:23.
14. Löwe B, Spitzer RL, Gräfe K, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnosis. J Affect Disord 2004;78:131-41.